In a statement, the U.S. Department of Justice stated, Gilead Sciences Inc has agreed to settle allegations that it improperly used the Caring Voice Coalition as a conduit to cover thousands of patients’ co-payment obligations and has agreed to pay… Read More ›
While the deal will boost Ipen’s cancer drug portfolio, Merrimack’s shareholders will receive a special dividend as an outcome of the deal. France-based drug manufacturer Ipsen SA, has disclosed it will be acquiring some assets from its U.S. peer Merrimack… Read More ›
manageria.biz 